The University of Virginia Center for Diabetes Technology has added new staff in order to take advantage of an endowment that will allow them to further develop more effective treatments. The plan is to make the treatment for people with diabetes better by doing things like genetic screening, custom plans, and developing immunotherapies.
- four new team members who were attracted by our goal of optimally treating and eventually curing type 1 diabetes
- Virginia Precision Individualized Medicine for Diabetes (PrIMeD) Project has received $16.9 million from UVA’s Strategic Investment Fund
- the center is part of a broader effort at UVA to screen, control and eliminate type 1 diabetes in Virginia
“”We want to provide state-of-the-art technology to all patients with diabetes under one roof,” Ananda Basu said.”